Mark A Sr Prygocki Clarus Therapeutics Holdings, Inc. (CRXT) insider trading activity

Mark A Sr Prygocki is Director of Clarus Therapeutics Holdings, Inc.. Currently has a direct ownership of 5,766 shares of CRXT, which is worth approximately $172. The most recent transaction as insider was on Jun 07, 2022, when has been sold 1,922 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.77K

0% 3M change

0% 12M change

Total Value Held $172

MARK A SR PRYGOCKI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 07 2022	BUY Grant, award, or other acquisition	-	1,922 Added 25.0%	5,766 Common Stock
Dec 12 2021	BUY Grant, award, or other acquisition	-	3,844 Added 50.0%	3,844 Common Stock

Also insider at

VRCA

Verrica Pharmaceuticals Inc. Healthcare

MAS